Dry Age-related Macular Degeneration Clinical Trials Database - Free Access to 19 Studies
Access comprehensive clinical trial information for Dry Age-related Macular Degeneration through Pure Global AI's free database. This collection includes 19 clinical trials across multiple phases including N/A, Phase 2, Early Phase 1. Currently, 7 trials are actively recruiting participants.
Research for Dry Age-related Macular Degeneration is being conducted in United States of America, China, Australia,France,Germany,Spain,United Kingdom,United States of America and 6+ other countries. Leading sponsors include LumiThera, Inc. and Gyroscope Therapeutics Limited. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)
Atrophic Age-related Macular Degeneration (AMD) Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP): a Pilot Study
QA102 Phase II Study in Subjects With Dry AMD
Safety and Tolerability of RPESC-derived RPE Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Microcurrent Stimulation for Dry Age-related Macular Degeneration
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Observational Study of Vision Improvement in Late Stage Dry AMD Patients
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)
A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration
PRIMA US-Feasibility Study in Atrophic Dry AMD
Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration
Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells
Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases
Untitled Trial
A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration
Pure Global AI provides free access to 19 clinical trials studying Dry Age-related Macular Degeneration, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 9+ countries.
Top research sponsors include LumiThera, Inc., Gyroscope Therapeutics Limited, Chinese Academy of Sciences, among others.